Graft-versus-leukemia effects of transplantation and donor lymphocytesKOLB, Hans-Jochem.Blood. 2008, Vol 112, Num 12, pp 4371-4383, issn 0006-4971, 13 p.Article

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantationKOLB, H.-J.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 321-329, issn 0042-9007, SUP2Conference Paper

Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia? Authors' replyCHUNDURI, S; DOBOGAI, L. C; BRUNO, A et al.Leukemia. 2005, Vol 19, Num 3, pp 456-457, issn 0887-6924, 2 p.Article

Stem cell transplantation-harnessing of graft-versus-malignancyANTIN, Joseph H.Current opinion in hematology. 2003, Vol 10, Num 6, pp 440-444, issn 1065-6251, 5 p.Article

Graft-versus-leukemia in chronic lymphocytic leukemiaBEN-BASSAT, I; RAANANI, P; GALE, R. P et al.Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 8, pp 441-446, issn 0268-3369, 6 p.Article

GVL effect in plasmacytoid DC leukemia/lymphomaKALOYANNIDIS, P; ZOMAS, A; PATERAKIS, G et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 5, pp 961-962, issn 0268-3369, 2 p.Article

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantationRIDDELL, Stanley R; BERGER, Carolina; MURATA, Makoto et al.Blood reviews. 2003, Vol 17, Num 3, pp 153-162, issn 0268-960X, 10 p.Article

Perspectives d'immunothérapie des hémopathies malignes = New strategies in immunotherapy for hematologic malignanciesBUZYN, A; OSTANKOVITCH, M; KEMULA, M et al.Hématologie (Montrouge). 1997, Vol 3, Num 6, pp 518-527, issn 1264-7527Article

Understanding and harnessing the graft-versus-leukaemia effectBARRETT, A. John.British journal of haematology. 2008, Vol 142, Num 6, pp 877-888, issn 0007-1048, 12 p.Article

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia : a single center experience of 23 patientsKORTHOF, E. T; SNIJDER, P. P; DE GRAAFF, A. A et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 5, pp 455-461, issn 0268-3369, 7 p.Article

Overexpressed differentiation antigens as targets of graft-versus-leukemia reactionsMOLLDREM, Jeffrey J; KOMANDURI, Krishna; WIEDER, Eric et al.Current opinion in hematology. 2002, Vol 9, Num 6, pp 503-508, issn 1065-6251, 6 p.Article

Hematopoietic cell transplantation in older patients with hematologic malignancies : replacing high-dose cytotoxic therapy with graft-versus-tumor effectsMCSWEENEY, Peter A; NIEDERWIESER, Dietger; RADICH, Jerald et al.Blood. 2001, Vol 97, Num 11, pp 3390-3400, issn 0006-4971Article

Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine modelSHAPIRA, Michael Y; HIRSHFELD, Ester; WEISS, Lola et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 4, pp 383-388, issn 0340-7004, 6 p.Article

Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines : relevance for allogeneic immunotherapy of leukemiaKLOOSTERBOER, Freke M; VAN LUXEMBURG-HEIJS, Simone A. P; VAN SOEST, Ronald A et al.Blood. 2005, Vol 106, Num 12, pp 3955-3957, issn 0006-4971, 3 p.Article

Données nouvelles sur la thérapie cellulaire = New data on the cellular therapyBOURHIS, Jean-Henri.Hématologie (Montrouge). 2001, Vol 7, Num MAR, pp 22-26, issn 1264-7527, NSArticle

The graft-versus-leukemia effects of allogeneic cell therapyPORTER, D. L; ANTIN, J. H.Annual review of medicine. 1999, Vol 50, pp 369-386, issn 0066-4219Article

Extra-medullary relapse of leukemia following allogeneic bone marrow transplantationAU, W. Y; KWONG, Y. L; LIE, A. K. W et al.Hematological oncology. 1999, Vol 17, Num 2, pp 45-52, issn 0278-0232Article

Adoptive immunotherapy using donor leukocyte infusions to treat relapsed hematologic malignancies after allogeneic bone marrow transplantationDROBYSKI, W. R.Cancer treatment and research. 1999, Vol 101, pp 233-266, issn 0927-3042Article

In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantationFEGAN, C; THOMAS, H; BAILEY-WOOD, R et al.Bone marrow transplantation (Basingstoke). 1995, Vol 16, Num 2, pp 277-281, issn 0268-3369Article

Type I-IFNs control GVHD and GVL responses after transplantationROBS, Renee J; KREIJVELD, Ellen; MARKEY, Kate A et al.Blood. 2011, Vol 118, Num 12, pp 3399-3409, issn 0006-4971, 11 p.Article

Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cellsMEGURO, A; OZAKI, K; NAKAE, S et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 12, pp 1557-1565, issn 0268-3369, 9 p.Article

Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte InfusionWANDI ZHANG; CHOI, Jaewon; RITZ, Jerome et al.Clinical cancer research (Print). 2010, Vol 16, Num 10, pp 2729-2739, issn 1078-0432, 11 p.Article

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantationVAGO, Luca; FORNO, Barbara; MIDDLETON, Derek et al.Blood. 2008, Vol 112, Num 8, pp 3488-3499, issn 0006-4971, 12 p.Article

Cytokines in Graft-Versus-Host disease and the graft-versus-leukemia reactionDEEG, H. Joachim.International journal of hematology. 2001, Vol 74, Num 1, pp 26-32, issn 0925-5710Article

High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantationLEE, K.-H; LEE, J.-H; KIM, S et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 2, pp 147-152, issn 0268-3369Article